Core Insights - The founder and chairman of Peninsula Medical Group, Lei Xiaobing, transitioned from being a surgeon in Chongqing to the medical aesthetics industry in Shenzhen, emphasizing the importance of research and providing cost-effective services to the public [7][8]. Company Development - Peninsula Medical was established in 2008 by Lei Xiaobing and several colleagues with medical backgrounds, initially exploring various medical fields before focusing on dermatology [7]. - The company achieved a significant breakthrough in 2011 by collaborating with the dermatology department of the Air Force General Hospital to develop the world's first "red and blue light therapy device," which has become a standard in top-tier hospitals [7]. Location Advantage - The decision to relocate the company headquarters to Shenzhen in 2015 was driven by the city's favorable industrial environment, which supports rapid product development and production [8]. - Shenzhen's efficient supply chain allows for quick prototyping and iteration, significantly enhancing the company's competitive edge in the market [8]. Research and Development - Research and development are central to the company's growth, with approximately 400 R&D personnel, accounting for about 30% of the total workforce, and over 1,000 patent applications filed [8][9]. - The company has received over 70 global certifications, including FDA, CE, and NMPA, for its various "star products," which have positioned it as a leader in multiple segments of the medical aesthetics industry [9]. Market Position - Peninsula Medical's "Peninsula Ultrasound Cannon" dominates 80% of the domestic medical aesthetics ultrasound market, while its self-developed "Peninsula Gold Micro-needle" competes effectively with international brands and has recently obtained FDA 510(k) registration, facilitating entry into the North American market [9].